Hereditary Hemolytic Anemia in Children

Hereditary Hemolytic Anemia in Children: Hemoglobinopathies, Thalassemia and Sickle Cell Disease — Etiopathogenesis, Clinical Features, Diagnosis, Differential Diagnosis, Management and Prevention This educational narrative review by Aditya Garad provides an overview of hereditary hemolytic anemia in children, with particular emphasis on thalassemia and sickle cell disease. It discusses the underlying genetic mechanisms, pathophysiology, clinical manifestations, diagnostic investigations, differential diagnosis, complications, management strategies, and preventive approaches associated with these inherited hematological disorders. The article describes the role of complete blood count, peripheral blood smear examination, reticulocyte count, hemolysis markers, hemoglobin analysis, and molecular genetic testing in the diagnostic evaluation of affected children. It also reviews current principles of pediatric care, including infection prevention, vaccination, hydroxyurea therapy for sickle cell disease, transfusion support, iron chelation therapy for selected thalassemia syndromes, and specialist assessment for potentially curative treatments. Additional topics include genetic inheritance, newborn screening, carrier screening, genetic counselling, long-term follow-up, psychosocial support, and public-health strategies for improving early diagnosis and access to care. The review highlights the importance of individualized treatment, multidisciplinary collaboration, and timely recognition of complications to improve health outcomes and quality of life in affected children. This manuscript is a narrative educational review based on published medical literature and clinical guidance from organizations and resources including the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the National Heart, Lung, and Blood Institute (NHLBI), GeneReviews, and peer-reviewed publications. It does not report original patient data or experimental findings. Keywords: Hereditary hemolytic anemia; pediatric hematology; hemoglobinopathies; thalassemia; sickle cell disease; hemolysis; hemoglobin electrophoresis; newborn screening; genetic counselling; anemia in children. Disclaimer: This article is intended for educational and academic purposes only. It does not replace professional medical advice, individualized clinical assessment, or current treatment guidelines.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-14
DOI
https://doi.org/10.5281/zenodo.23374454
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hereditary Hemolytic Anemia in Children

Adityayoga Adityayoga
Zenodo (CERN European Organization for Nuclear Research)
Hemoglobinopathies and Related Disorders
article

Hereditary Hemolytic Anemia in Children

Adityayoga Adityayoga
article en

Abstract

Hereditary Hemolytic Anemia in Children: Hemoglobinopathies, Thalassemia and Sickle Cell Disease — Etiopathogenesis, Clinical Features, Diagnosis, Differential Diagnosis, Management and Prevention This educational narrative review by Aditya Garad provides an overview of hereditary hemolytic anemia in children, with particular emphasis on thalassemia and sickle cell disease. It discusses the underlying genetic mechanisms, pathophysiology, clinical manifestations, diagnostic investigations, differential diagnosis, complications, management strategies, and preventive approaches associated with these inherited hematological disorders. The article describes the role of complete blood count, peripheral blood smear examination, reticulocyte count, hemolysis markers, hemoglobin analysis, and molecular genetic testing in the diagnostic evaluation of affected children. It also reviews current principles of pediatric care, including infection prevention, vaccination, hydroxyurea therapy for sickle cell disease, transfusion support, iron chelation therapy for selected thalassemia syndromes, and specialist assessment for potentially curative treatments. Additional topics include genetic inheritance, newborn screening, carrier screening, genetic counselling, long-term follow-up, psychosocial support, and public-health strategies for improving early diagnosis and access to care. The review highlights the importance of individualized treatment, multidisciplinary collaboration, and timely recognition of complications to improve health outcomes and quality of life in affected children. This manuscript is a narrative educational review based on published medical literature and clinical guidance from organizations and resources including the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the National Heart, Lung, and Blood Institute (NHLBI), GeneReviews, and peer-reviewed publications. It does not report original patient data or experimental findings. Keywords: Hereditary hemolytic anemia; pediatric hematology; hemoglobinopathies; thalassemia; sickle cell disease; hemolysis; hemoglobin electrophoresis; newborn screening; genetic counselling; anemia in children. Disclaimer: This article is intended for educational and academic purposes only. It does not replace professional medical advice, individualized clinical assessment, or current treatment guidelines.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 14%
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.